Professor Elijah Behr

Clinical interests

Professor Behr’s interests include:

• Management of families with unexplained sudden deaths, the Sudden Arrhythmic Death Syndrome (SADS) and Sudden Infant Death Syndrome (SIDS)
• Ion channel diseases including the long QT and Brugada syndromes
• Drug-induced arrhythmia and QT prolongation
• Hypertrophic, dilated and arrhythmogenic right ventricular cardiomyopathies
• Management of sudden death risk
• Management and treatment of arrhythmias
• Ablation of simple and complex arrhythmias including atrial fibrillation
• Complex device therapy (ICD implantation and biventricular pacing)

Professional profile

Professor Behr is a recognised national and international expert and researcher in the field of arrhythmias. He is Professor in Cardiovascular Medicine and Honorary Consultant Cardiologist specialising in Electrophysiology at St George's, University of London and St George's Hospital, London. He runs an Arrhythmia service and co-leads the Inherited Cardiac Conditions clinic at St George's, coordinating a multi-disciplinary team that provides a single one-stop service to families including children.

Professor Behr was educated at the Manchester Grammar School and studied medical  sciences at St John's College, University of Cambridge and clinical medicine at Guy's  Hospital, London where he graduated with distinction. He completed cardiology and academic training at St George’s Hospital, London.

Professor Behr is president of  the Association for Inherited Cardiac Conditions (AICC).  He is an editorial board  member of the Heart Rhythm journal and co-wrote international  guidelines for diagnosis & management of  arrhythmia syndromes. He is a Health Care  Partner lead for the European Rare Disease Reference Network GUARD-HEART and co-chairs the South London ICC (SLICC) network. Professor Behr has founded the European Cardiac Arrhythmia Genetics (ECGen) Group of the European Heart Rhythm association.

Professor Behr’s research  interests include prediction of sudden death risk pathology,   genomics and epidemiology linked to electronic health records; drug-induced arrhythmia; families with  unexplained sudden deaths, the Sudden Arrhythmic Death   Syndrome  (SADS) and Sudden Infant Death Syndrome (SIDS); ion channel diseases  including  the  long  QT and Brugada syndromes; and cardiomyopathies including arrhythmogenic right ventricular cardiomyopathy (ARVC).